223. Primary membranoproliferative glomerulonephritis
18 clinical trials,   14 drugs   (DrugBank: 7 drugs),   7 drug target genes,   14 drug target pathways

Other name(s) = "Dense deposit disease"

Specific pediatric chronic diseases, Japan
• 2-2-9. Membranoproliferative glomerulonephritis; MPGN